• Contact Us

Join us! Advancing Cell + Gene Therapies for Cancer | Oct. 15-16, 2025 | Philadelphia + On Demand

• Annual Meeting
  • Register
  • Sponsor & Exhibit
  • Future Annual Meetings
  • Annual Meeting Archives
    • 27th Annual Meeting Video Archive

  • Program
    • Certificate of Attendance
    • Workshops
    • Keynote Speakers

  • Abstracts
    • Present
    • Awards
    • Topics
• Membership
  • Video Library
    • Annual Meeting
    • Cancer
    • Career Skills
    • Gene Editing
    • Patients and Clinicians
    • Regulatory
    • Viral Vectors

  • Become a Member
  • Get Involved
  • Awards
  • Membership Directory
  • Scientific Committees
  • Standing Committees

  • My Profile
  • Career Center
  • ASGCT Abstracts
    • Abstract Submission Windows
  • Volunteer
• Events
  • Advancing Cell and Gene Therapies for Cancer
    • Registration + Rates
  • Policy Summit 2025
    • Register

  • Around the World: How U.S. Science Is Impacting Cell and Gene Therapy Globally
  • Empowering Patients Summit
  • Professional Development Cafés

  • Breakthroughs in Targeted In Vivo Gene Editing
    • Registration + Rates
    • Submit an Abstract
• Awards
  • Honorific Awards
    • Outstanding Achievement Award
    • Outstanding New Investigator Awards
    • George Stamatoyannopoulos Mentorship Award
    • Award for Excellence in Advancing Diversity, Equity, and Inclusion
    • Exemplary Service Award

  • Annual Meeting Awards
  • Underrepresented Populations in Gene and Cell Therapy
  • Mavis Agbandje-McKenna Scholarship and Fund

  • Career Development Awards
  • Congressional Policy Fellowship
• Outreach
  • Patient Education: Gene Therapy 101
    • Gene Therapy Basics
    • Gene Therapy Approaches
    • Clinical Trials Process
    • Vectors 101
    • Gene Editing
  • Global Outreach
    • 2025 Global Gene Therapy Training Course

  • Patient Education: Condition Treatments
    • Beta Thalassemia & Other Blood Disorders
    • CALD and MLD
    • Spinal Muscular Atrophy
    • CAR-T Basics
    • Hemophilia

  • Community Quick Takes
    • AAV Immune Response
    • Focused Ultrasound in CGT
    • Informed Consent
    • State of the Field Highlights + Approvals for CGT in 2023
    • Access to Approved Cell and Gene Therapies
    • Genetic Testing and Clinical Trial Eligibility
• Publications
  • ASGCT Blog
  • The Patient Press
    • August 2025
  • The Vector
  • Quarterly Gene, Cell, and RNA Therapy Landscape Report

  • ASGCT Podcast Network
    • Giants of Gene Therapy
    • The Issue
    • The Molecular Therapy Podcast
  • The Advocate
    • Subscribe to The Advocate

  • Molecular Therapy Family
    • Molecular Therapy
    • MT Methods & Clinical Development
    • MT Nucleic Acids
    • MT Oncology
• Advocacy
  • Events and Opportunities
    • Class Considerations on Immunogenicity for AAV Gene Therapy Products
    • Policy Summit
    • ASGCT-FDA Liaison Meeting
    • Cell + Gene Therapy Science Series
    • Congressional Policy Fellowship

  • Policy Priorities
    • Patient Access Overview
    • Regulatory Policy
    • Research Funding

  • The Advocate
    • Subscribe to The Advocate
  • Policy Statements & Letters
• About
  • Leadership
    • Board of Directors
    • Scientific Committees
    • Standing Committees
    • Staff
  • Work at ASGCT
    • Strategic Development Manager

  • Media
  • Our Culture
  • Strategic Plan
  • Meeting Code of Conduct
  • ASGCT Event Policies

  • Mission & Vision
    • Bylaws
  • Support ASGCT
    • Annual Meeting Support
    • Advertise in ASGCT Publications
    • Digital Programs
    • Giving
    • Patient Education
    • Year-Round Support

The Advocate

ASGCT's policy and advocacy-focused newsletter.

Subscribe to The Advocate

Receive The Advocate in your inbox every month to stay up to date on ASGCT's policy and advocacy-related actions to advance gene and cell therapies! 

Subscribe

Read Archived Issues

September 2024

In this issue: Read our recent comments to FDA and CMS, check out our latest Community Quick Takes module on genetic testing and clinical trial access, stay up to date on policy news, and more.

Read the issue